Monica Mead

机构：University of California, Los Angeles, Clinical Solutions

发表论文 4 篇 · 总被引 59 次 · h-index 1

代表论文

• Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 57)
• Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma (2026 · Journal of Clinical Oncology · 被引 1)
• Combination of Glofitamab with Pirtobrutinib in BTK Inhibitor (BTKi)-Naive or Btki-Intolerant Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium (2024 · Blood · 被引 1)
• The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator (2024 · SSRN Electronic Journal)